McNeil gelcaps patent
This article was originally published in The Tan Sheet
Executive Summary
Firm's OTCs that use gelatin capsule technology covered by '524 patent include Tylenol cough/cold products, not cough/cold offerings under the Motrin brand, as incorrectly stated in 1"The Tan Sheet" Aug. 5, 2002, p. 13...You may also be interested in...
McNeil Gelatin Capsules Patent Infringed By Bayer, Jury Says
Two gelcap formulations of Bayer aspirin infringe a McNeil-PPC patent covering dual-colored, gelatin-coated caplets, a jury concluded July 26
Germany's OTC Market in 2019: Stagnation Overall, Online Growth Continues
A weak cough and cold season in Germany last winter held back OTC sales growth in 2019, according to IQVIA, while the country's online pharmacy channel continued to expand.
Stockwatch: Choppy Waters For Teva And Bausch
After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: